南京招聘

Roles and Responsibilities:

• Support surgical division on overall sales planning, target setting, dealer management policy and development of quota and KPIs for sales team
• Coordinate top-down and cross-function communication on sales planning, resource requirement. Strategy and action plan follow up.
• Supervise data management system and process including data collection, analysis and reporting, make sure data quality, consistency and on time delivery
• Develop framework and methodology for business analysis. Data analysis by region with regard to SN and competitor on a monthly basis. Provide analytical support management decision and quarterly review. Align with cross functions with regard to execution and coordination
• Observe daily business operation and identify opportunity to improve efficiency
• Drive and supervise projects to improve SFE in surgical division
• Provide recommendation for organization structure and headcount planning from SFE perspective Mange the cost

Requirement:

• Bachelor Degree above
• At least 2 years business analyst or sales planning experience in medical device industry
• Strong analytical and communication skills, process driven, sense of analysis

Smith & Nephew is a diversified advanced medical technology business that supports healthcare professionals in more than 100 countries to improve the quality of life for their patients.
 
We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma:
?    Orthopedics Reconstruction - joint replacement systems for knees, hips and shoulders
?    Advanced Wound Management - wound care treatment and prevention products used to treat hard to heal wounds
?    Sports Medicine - minimally invasive surgery of the joint
?    Trauma & Extremities - products that help repair broken bones

We have over 15,000 employees around the world. Annual sales in 2016 were more than $4.6 billion.
We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN) .